Prestige Consumer Healthcare Inc.

NYSE:PBH

Medical - Distribution

Healthcare
$50.62 +0.49%

+$0.23 today

Market cap
$2.40B
Beta
0.35
P/E (TTM)
11.6
EPS (TTM)
$4.01
52W Low $42.62High $85.29

Volume 0.62M

Average 0.67M

PBH Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Prestige Consumer Healthcare Inc.NYSE: PBH

Net Margin · Q1 FY2027 · quarter ended Jun 2026

Net margin narrows to 11.0%

Net margin was 11.0% in Q1 FY2027, down 8.0 pp from a year earlier. On a trailing-twelve-month basis it was 15.6%, down 3.4 pp year over year. Over 3 fiscal years it widened by 24.8 pp.

Context

  • Net margin widened in 2 of the last 3 fiscal years.

What to watch

Whether net margin reaches the consensus estimate from 6 analysts of 17.2% for the fiscal year ending Mar 2027, down from 17.5% in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
11.0%-8.2 pp QoQ
Last fiscal yearMar 2026
17.5%-1.4 pp YoY
LTMJun 2026
15.6%-3.4 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-8.0 pp+0.1 pp+8.2 pp
1 year-1.4 pp-0.3 pp+1.1 pp
3 years+24.8 pp+1.2 pp-23.6 pp
5 years+3.0 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2026
17.5%
Year-over-year change
-1.4pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How PBH compares with its peers on the latest reported figures

  • PBH's LTM Jun 2026 net margin of 15.6% is the 2nd highest of the 10 companies compared; the peer median is 1.2%.
  • Its year-over-year change of -3.4 pp is the lowest of 10, against a peer median of +7.8 pp.
  • Over three fiscal years its change of +24.8 pp compares with a peer median of +2.5 pp.
PBH Competitors Peer median
Net Margin for PBH and competitors
Company Period LTM level YoY 3-year change
CPRXCatalyst Pharmaceuticals, Inc.LTM Mar 202637.1% +0.2 pp-2.4 pp
PBHPrestige Consumer Healthcare Inc.LTM Jun 202615.6% -3.4 pp+24.8 pp
LIVNLivaNova PLCLTM Sep 202613.0% +29.1 pp-9.0 pp
CONConcentra Group Holdings Parent, Inc.LTM Sep 20269.3% +1.9 pp-2.0 pp
ICUIICU Medical, Inc.LTM Jun 20261.4% +3.0 pp+3.3 pp
PRVAPrivia Health Group, Inc.LTM Jun 20261.2% +0.4 pp+1.7 pp
LEGNLegend Biotech CorporationLTM Sep 2026-0.0% +26.4 pp+352.6 pp
ATECAlphatec Holdings, Inc.LTM Mar 2026-15.9% +9.8 pp+24.4 pp
HTFLHeartflow, Inc. Common StockLTM Sep 2026-33.1% +44.3 pp—
ZLABZai Lab LimitedLTM Jun 2026-41.9% +7.8 pp+168.0 pp
IRONDisc Medicine, Inc.FY2025— ——
Peer median (excluding PBH) 1.2%+7.8 pp+2.5 pp

Competitors are the stored peer set for PBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue1.09B1.13B1.13B1.14B1.09B
Cost of Revenue466.17M502.43M500.91M503.3M514.07M
Gross Profit620.65M625.29M624.45M634.46M574.64M
Gross Margin57.1%55.4%55.5%55.8%52.8%
Research & Development00000
Selling, General & Admin264.8M252.42M259.47M263.93M265.23M
Operating Expenses290.73M647.71M282.02M297.69M265.23M
Depreciation & Amortization32.09M32.63M30.68M30.17M31.27M
EBITDA358.84M7.87M373.86M361.99M331.11M
EBITDA Margin33.0%0.7%33.2%31.8%30.4%
Operating Income329.92M(22.42M)342.43M336.78M309.41M
Operating Margin30.4%-2.0%30.4%29.6%28.4%
Interest Income00000
Interest Expense64.29M69.16M67.16M47.63M42.34M
Other Income / Expenses(67.46M)(71.5M)(66.4M)(52.59M)(51.91M)
Income Before Tax262.46M(93.92M)276.03M284.19M257.5M
Pre-Tax Margin24.1%-8.3%24.5%25.0%23.7%
Income Tax Expense57.08M(11.61M)66.69M69.58M67.2M
Net Income205.38M(82.31M)209.34M214.61M190.3M
Net Margin18.9%-7.3%18.6%18.9%17.5%
EPS (Basic)4.09(1.65)4.214.323.93
EPS (Diluted)4.04(1.65)4.174.293.91
Weighted Avg Shares50.26M49.88M49.76M49.7M48.46M
Weighted Avg Shares (Diluted)50.84M49.89M50.18M50.08M48.72M

Prestige Consumer Healthcare Inc.

NYSE:PBH

Intrinsic Alpha fair value

Locked

Current Price

$50.62

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.